newsfilter
← Latest News
GlobeNewswire·

Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference

CUPERTINO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet